| Angela Waite, MS, FAAA | |
|
9103 Franklin Square Dr Ste 302, Baltimore, MD 21237-3900 | |
| (410) 248-6300 | |
| (410) 686-4973 |
| Full Name | Angela Waite |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 9103 Franklin Square Dr Ste 302, Baltimore, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609947829 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 645 (Maryland) | Primary |
| Provider Name | Centers For Advanced Ent Care Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1447781620 PECOS PAC ID: 1658647359 Enrollment ID: O20171025001018 |
News Archive
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
Location Based Technologies, Inc., a leading-edge service provider of personal, pet, and asset location devices, today announced that they have received an order from Stephen Gould Corporation for specialized medical equipment and asset tracking devices that will be utilized by a Southern California medical company.
A Canadian tourist suffered a serious heart inflammation called myocarditis after he was bitten by a poisonous spider when he went swimming nude in New Zealand.
Scientists at the University of Basel in Switzerland have, for the first time, described a new T cell population that can recognize and kill tumor cells. The open access journal eLife has published the results.
Gilead Sciences, Inc. today announced that detailed results from four Phase 3 clinical trials (NEUTRINO, FISSION, POSITRON and FUSION) evaluating sofosbuvir, the company's investigational once-daily nucleotide NS5B inhibitor for the treatment of chronic hepatitis C virus infection, will be presented this week in oral sessions at the 48th Annual Meeting of the European Association for the Study of the Liver in Amsterdam, The Netherlands.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angela Waite, MS, FAAA 520 Upper Chesapeake Dr Ste 206, Bel Air, MD 21014-4360 Ph: (410) 879-9100 | Angela Waite, MS, FAAA 9103 Franklin Square Dr Ste 302, Baltimore, MD 21237-3900 Ph: (410) 248-6300 |
News Archive
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
Location Based Technologies, Inc., a leading-edge service provider of personal, pet, and asset location devices, today announced that they have received an order from Stephen Gould Corporation for specialized medical equipment and asset tracking devices that will be utilized by a Southern California medical company.
A Canadian tourist suffered a serious heart inflammation called myocarditis after he was bitten by a poisonous spider when he went swimming nude in New Zealand.
Scientists at the University of Basel in Switzerland have, for the first time, described a new T cell population that can recognize and kill tumor cells. The open access journal eLife has published the results.
Gilead Sciences, Inc. today announced that detailed results from four Phase 3 clinical trials (NEUTRINO, FISSION, POSITRON and FUSION) evaluating sofosbuvir, the company's investigational once-daily nucleotide NS5B inhibitor for the treatment of chronic hepatitis C virus infection, will be presented this week in oral sessions at the 48th Annual Meeting of the European Association for the Study of the Liver in Amsterdam, The Netherlands.
› Verified 4 days ago
Ms. Terese D Beauchamp, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 7658a Belair Rd, Baltimore, MD 21236 Phone: 410-668-9198 | |
Shannon Hahn, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 200 E 33rd St, Baltimore, MD 21218 Phone: 410-554-4455 | |
Total Audiology Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 733 W 40th St Ste 20, Baltimore, MD 21211 Phone: 410-877-0795 Fax: 877-766-8925 | |
Estelle Skinner, MS, CCC/A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2500 E Northern Pkwy, Baltimore, MD 21214 Phone: 410-515-6548 | |
Devra Brace, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 6565 N Charles St Ste 601, Baltimore, MD 21204 Phone: 410-821-5151 Fax: 410-823-8309 | |
Ms. Cynthia Ann Fannon, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 6565 N Charles St, Suite 601, Baltimore, MD 21204 Phone: 410-821-5151 | |
Erin Mcdermott, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3801 Gough St, Baltimore, MD 21224 Phone: 131-572-0456 |